Boston Scientific (BSX) EBITDA Margin (2009 - 2026)
Boston Scientific (BSX) reported EBITDA Margin of 21.16% for Q1 2026, up 141.0% on a YoY basis from 8.78% in Q1 2025, and up 35.58% sequentially from 15.61% in Q4 2025.
Boston Scientific (BSX) EBITDA Margin (2009 - 2026) Analysis & Trends
Boston Scientific (BSX) has 18 years of EBITDA Margin data on file, last reported at 21.16% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 141.0% year-over-year to 21.16%; the trailing twelve-month figure through Mar 2026 stood at 18.4% (up 217.0% YoY), and the FY2025 full-year result was 18.0%, up 246.0% from the prior year.
- EBITDA Margin grew to 21.16% in Q1 2026, from 15.61% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 21.16% in Q1 2026 to a low of 11.29% in Q3 2022.
- A 5-year average of 16.1% and a median of 15.68% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 836 bps in 2023 and plunged 223 bps in 2024, its largest moves.
- Tracing BSX's EBITDA Margin over 5 years: stood at 12.4% in 2022, then climbed by 26 bps to 15.68% in 2023, then slipped by 6 bps to 14.8% in 2024, then gained by 5 bps to 15.61% in 2025, then jumped by 36 bps to 21.16% in 2026.
- Business Quant data shows BSX's EBITDA Margin at 21.16% in Q1 2026, 15.61% in Q4 2025, and 20.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 6.17% |
| 10 | Steris | 21.46 Bn | 21.02 Bn | 697.10 Mn | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.16% |
| Dec 31, 2025 | 15.61% |
| Sep 30, 2025 | 20.69% |
| Jun 30, 2025 | 16.18% |
| Mar 31, 2025 | 19.75% |
| Dec 31, 2024 | 14.80% |
| Sep 30, 2024 | 17.42% |
| Jun 30, 2024 | 12.62% |
| Mar 31, 2024 | 17.51% |
| Dec 31, 2023 | 15.68% |
| Sep 30, 2023 | 19.65% |
| Jun 30, 2023 | 14.28% |
| Mar 31, 2023 | 16.29% |
| Dec 31, 2022 | 12.40% |
| Sep 30, 2022 | 11.29% |
| Jun 30, 2022 | 13.04% |
| Mar 31, 2022 | 15.40% |
| Dec 31, 2021 | 5.76% |
| Sep 30, 2021 | 13.20% |
| Jun 30, 2021 | 8.51% |